The rational design of a novel potent analogue of the 5′-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health
  • National Cancer Institute

This publication has 23 references indexed in Scilit: